Literature DB >> 25398344

Creating cancer translocations in human cells using Cas9 DSBs and nCas9 paired nicks.

Benjamin Renouf1, Marion Piganeau1, Hind Ghezraoui1, Maria Jasin2, Erika Brunet3.   

Abstract

Recurrent chromosomal translocations are found in numerous tumor types, often leading to the formation and expression of fusion genes with oncogenic potential. Creating chromosomal translocations at the relevant endogenous loci, rather than ectopically expressing the fusion genes, opens new possibilities for better characterizing molecular mechanisms driving tumor formation. In this chapter, we describe methods to create cancer translocations in human cells. DSBs or paired nicks generated by either wild-type Cas9 or the Cas9 nickase, respectively, are used to induce translocations at the relevant loci. Using different PCR-based methods, we also explain how to quantify translocation frequency and to analyze breakpoint junctions in the cells of interest. In addition, PCR detection of translocations is used as a very sensitive method to detect off-target effects, which has general utility.

Entities:  

Keywords:  Cas9; Cas9D10A; Chromosomal translocations; DNA double-strand breaks; EWS–FLI1; NPM–ALK; Paired nicks; nCas9

Mesh:

Substances:

Year:  2014        PMID: 25398344      PMCID: PMC4398311          DOI: 10.1016/B978-0-12-801185-0.00012-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  29 in total

1.  Frequent chromosomal translocations induced by DNA double-strand breaks.

Authors:  C Richardson; M Jasin
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

2.  A rapid and general assay for monitoring endogenous gene modification.

Authors:  Dmitry Y Guschin; Adam J Waite; George E Katibah; Jeffrey C Miller; Michael C Holmes; Edward J Rebar
Journal:  Methods Mol Biol       Date:  2010

3.  Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

Authors:  M U Kuefer; A T Look; K Pulford; F G Behm; P K Pattengale; D Y Mason; S W Morris
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

4.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

Authors:  W A May; M L Gishizky; S L Lessnick; L B Lunsford; B C Lewis; O Delattre; J Zucman; G Thomas; C T Denny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

5.  A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair.

Authors:  David M Weinstock; Beth Elliott; Maria Jasin
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

6.  Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.

Authors:  P G Elmberger; M D Lozano; D D Weisenburger; W Sanger; W C Chan
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

7.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

Review 8.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

9.  Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining.

Authors:  Hind Ghezraoui; Marion Piganeau; Benjamin Renouf; Jean-Baptiste Renaud; Annahita Sallmyr; Brian Ruis; Sehyun Oh; Alan E Tomkinson; Eric A Hendrickson; Carine Giovannangeli; Maria Jasin; Erika Brunet
Journal:  Mol Cell       Date:  2014-09-04       Impact factor: 17.970

10.  Chromosomal translocations induced at specified loci in human stem cells.

Authors:  Erika Brunet; Deniz Simsek; Mark Tomishima; Russell DeKelver; Vivian M Choi; Philip Gregory; Fyodor Urnov; David M Weinstock; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-23       Impact factor: 11.205

View more
  9 in total

1.  Generation of chromosomal translocations that lead to conditional fusion protein expression using CRISPR-Cas9 and homology-directed repair.

Authors:  Fabio Vanoli; Maria Jasin
Journal:  Methods       Date:  2017-05-15       Impact factor: 3.608

2.  CRISPR-Cas9-guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells.

Authors:  Fabio Vanoli; Mark Tomishima; Weiran Feng; Khadija Lamribet; Loelia Babin; Erika Brunet; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-21       Impact factor: 11.205

3.  Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis.

Authors:  Minori Tamai; Shinichi Fujisawa; Thao T T Nguyen; Chiaki Komatsu; Keiko Kagami; Kenji Kamimoto; Kohei Omachi; Shin Kasai; Daisuke Harama; Atsushi Watanabe; Koshi Akahane; Kumiko Goi; Kazuhito Naka; Tadashi Kaname; Takanori Teshima; Takeshi Inukai
Journal:  Cancer Gene Ther       Date:  2022-08-23       Impact factor: 5.854

4.  Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9.

Authors:  Raul Torres-Ruiz; Marta Martinez-Lage; Maria C Martin; Aida Garcia; Clara Bueno; Julio Castaño; Juan C Ramirez; Pablo Menendez; Juan C Cigudosa; Sandra Rodriguez-Perales
Journal:  Stem Cell Reports       Date:  2017-05-09       Impact factor: 7.765

5.  IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche.

Authors:  Katarzyna J Grybel; Gregorio Alanis-Lobato; Sissy E Wamaitha; Claudia Gerri; Sugako Ogushi; Afshan McCarthy; Shantha K Mahadevaiah; Lyn Healy; Rebecca A Lea; Miriam Molina-Arcas; Liani G Devito; Kay Elder; Phil Snell; Leila Christie; Julian Downward; James M A Turner; Kathy K Niakan
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

6.  De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.

Authors:  Loélia Babin; Alice Darchen; Elie Robert; Zakia Aid; Rosalie Borry; Claire Soudais; Marion Piganeau; Anne De Cian; Carine Giovannangeli; Olivia Bawa; Charlotte Rigaud; Jean-Yves Scoazec; Lucile Couronné; Layla Veleanu; Agata Cieslak; Vahid Asnafi; David Sibon; Laurence Lamant; Fabienne Meggetto; Thomas Mercher; Erika Brunet
Journal:  Mol Cancer       Date:  2022-03-04       Impact factor: 27.401

7.  Marker-free co-selection for successive rounds of prime editing in human cells.

Authors:  Sébastien Levesque; Diana Mayorga; Jean-Philippe Fiset; Claudia Goupil; Alexis Duringer; Andréanne Loiselle; Eva Bouchard; Daniel Agudelo; Yannick Doyon
Journal:  Nat Commun       Date:  2022-10-07       Impact factor: 17.694

8.  Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.

Authors:  Didier Surdez; Erika Brunet; Anna Sole; Sandrine Grossetête; Maxime Heintzé; Loelia Babin; Sakina Zaïdi; Patrick Revy; Benjamin Renouf; Anne De Cian; Carine Giovannangeli; Cécile Pierre-Eugène; Isabelle Janoueix-Lerosey; Lucile Couronné; Sophie Kaltenbach; Mark Tomishima; Maria Jasin; Thomas G P Grünewald; Olivier Delattre
Journal:  Cancer Res       Date:  2021-08-02       Impact factor: 12.701

9.  Chromosomal Translocation Formation Is Sufficient to Produce Fusion Circular RNAs Specific to Patient Tumor Cells.

Authors:  Loelia Babin; Marion Piganeau; Benjamin Renouf; Khadija Lamribet; Cecile Thirant; Ludovic Deriano; Thomas Mercher; Carine Giovannangeli; Erika C Brunet
Journal:  iScience       Date:  2018-06-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.